Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Other Accumulated Expenses (2016 - 2025)

Marchex (MCHX) has 16 years of Other Accumulated Expenses data on record, last reported at $2.7 million in Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 34.74% to $2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 million, a 34.74% decrease, with the full-year FY2025 number at $2.7 million, down 34.74% from a year prior.
  • Other Accumulated Expenses reached $2.7 million in Q4 2025 per MCHX's latest filing, down from $3.6 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for MCHX hit a ceiling of $4.3 million in Q1 2023 and a floor of $2.7 million in Q4 2025.
  • A 5-year average of $3.7 million and a median of $3.7 million in 2021 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: crashed 65.76% in 2021, then surged 30.46% in 2024.
  • Tracing MCHX's Other Accumulated Expenses over 5 years: stood at $3.9 million in 2021, then decreased by 1.14% to $3.8 million in 2022, then decreased by 15.9% to $3.2 million in 2023, then soared by 30.46% to $4.2 million in 2024, then tumbled by 34.74% to $2.7 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for MCHX at $2.7 million in Q4 2025, $3.6 million in Q3 2025, and $3.7 million in Q2 2025.